Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomised, Open Label, Multicentre, Non-inferiority Clinical Trial for New Treatment Modalities for Cutaneous Leishmaniasis Caused by Leishmania Tropica, in Pakistan

NCT04268524 is registered in ClinicalTrials.gov with Medecins Sans Frontieres, Netherlands as lead sponsor.

NCT NCT04268524
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04268524 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomised, Open Label, Multicentre, Non-inferiority Clinical Trial for New Treatment Modalities for Cutaneous Leishmaniasis Caused by Leishmania Tropica, in Pakistan
Lead sponsor
Medecins Sans Frontieres, Netherlands
Phase
Phase 3
Overall status
Completed
Start date
October 7, 2022
Completion date
June 19, 2026
Enrollment
645 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

old world cutaneous leishmaniasis